Insulin resistance in patients with cardiac hypertrophy

Cardiovascular Research

Volumn 42, Issue 1, 1999, Pages 246-253

  Paternostro, Giovanni ^a   Pagano, Domenico ^b   Gnecchi Ruscone, Tomaso ^a   Bonser, Robert S ^b   Camici, Paolo G ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Glycolysis; Heart failure; Hyertrophy; Membrane transport; Positron emission tomography; Valve (disease)

Indexed keywords

GLUCOSE TRANSPORTER; INSULIN;

ADULT; AORTA STENOSIS; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART HYPERTROPHY; HEART MUSCLE BIOPSY; HEART MUSCLE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL;

AORTIC VALVE STENOSIS; BLOTTING, WESTERN; CARDIOMEGALY; CASE-CONTROL STUDIES; FASTING; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MYOCARDIUM; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032924246     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00233-8     Document Type: Article

References (70)

1. Ferrannini E., Natali A. Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J. 121:1991;1274-1282.
2. Paternostro G., Camici P.G., Lammerstma A.A.et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest. 98:1996;2094-2099.
3. Liedtke A.J., Nellis S.H., Whitesell L.F. Effects of regional ischemia on metabolic function in adjacent aerobic myocardium. J Mol Cell Cardiol. 14:1982;195-205.
4. Nuutila P., Knuuti J., Ruotsalainen U.et al. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. Am J Physiol. 264:1993;E756-E762.
5. vom Dahl J., Herman W.H., Hicks R.J.et al. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. Circulation. 88:1993;395-404.
6. Nuutila P., Maki M., Laine H.et al. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest. 96:1995;1003-1009.
7. Camici P., Ferrannini E., Opie L.H. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis. 32:1989;217-238.
8. Ferrannini E., Santoro D., Bonadonna R.et al. Metabolic and hemodynamic effects of insulin on human hearts. Am J Physiol. 264:1993;E308-E315.
9. Rogers W.J., Russell R.O. Jr., McDaniel H.G., Rackley C.E. Acute effects of glucose-insulin-potassium infusion on myocardial substrates, coronary blood flow and oxygen consumption in man. Am J Cardiol. 40:1977;421-428.
10. Oliver M.F., Opie L.H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 343:1994;155-158.
11. Camici P., Araujo L.I., Spinks T.et al. Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation. 74:1986;81-88.
12. + channels. Evidence for preferential regulation by glycolysis. J Gen Physiol. 94:1989;911-935.
13. +)-ATPase in cultured cells. Biochim Biophys Acta. 804:1984;419-426.
14. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol. 19:1994;59-113.
15. Gould G.W., Bell G.I. Facilitative glucose transporters: an expanding family. Trends Biochem Sci. 15:1990;18-23.
16. Young L.H., Renfu Y., Russell R.et al. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation. 95:1997;415-422.
17. Slot J.W., Geuze H.J., Gigengack S., James D.E., Lienhard G.E. Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci USA. 88:1991;7815-7819.
18. Barnard R.J., Youngren J.F. Regulation of glucose transport in skeletal muscle. FASEB J. 6:1992;3238-3244.
19. Garvey W.T., Maianu L., Huecksteadt T.P.et al. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J Clin Invest. 87:1991;1072-1081.
20. Sinha M.K., Raineri Maldonado C., Buchanan C.et al. Adipose tissue glucose transporters in NIDDM. Decreased levels of muscle/fat isoform. Diabetes. 40:1991;472-477.
21. Vogt B., Muhlbacher C., Carrascosa J.et al. Subcellular distribution of GLUT 4 in the skeletal muscle of lean type 2 (non-insulin-dependent) diabetic patients in the basal state. Diabetologia. 35:1992;456-463.
22. Paternostro G., Clarke K., Heath J., Seymour A.M., Radda G.K. Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc Res. 30:1995;205-211.
23. Weinberg EO, Thienelt CD, Lorell BH. Pretranslational regulation of glucose transporter isoform expression in hearts with pressure-overload left ventricular hypertrophy. Circulation 1995;92:I-385.
24. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:1979;E214-E223.
25. Lentner C. Geigy scientific tables. Vol. 5. Basel: Ciba-Geigy, 1990.
26. Araujo L.I., Lammertsma A.A., Rhodes C.G.et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation. 83:1991;875-885.
27. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 3:1983;1-7.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
29. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989.
30. Brant A.M., McCoid S., Thomas H.M.et al. Analysis of the glucose transporter content of islet cell lines: implications for glucose-stimulated insulin release. Cell Signal. 4:1992;641-650.
31. Piper R.C., Hess L.J., James D.E. Differential sorting of two glucose transporters expressed in insulin-sensitive cells. Am J Physiol. 260:1991;C570-C580.
32. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Scientific, 1994.
33. Katz E.B., Stenbit A.E., Hatton K., DePinho R., Charron M.J. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature. 377:1995;151-155.
34. Sun D., Nguyen N., DeGrado T.R., Schwaiger M., Brosius F.Cr. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation. 89:1994;793-798.
35. Roberts R. Molecular basis of cardiology. Cambridge, MA: Blackwell Scientific, 1993.
36. Wang C., Hu S.M. Developmental regulation in the expression of rat heart glucose transporters. Biochem Biophys Res Commun. 177:1991;1095-1100.
37. Santalucia T., Camps M., Castello A.et al. Developmental regulation of GLUT-1 (erythroid/Hep G2) and GLUT-4 (muscle/fat) glucose transporter expression in rat heart, skeletal muscle, and brown adipose tissue. Endocrinology. 130:1992;837-846.
38. Izumo S., Lompre A.M., Matsuoka R.et al. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest. 79:1987;970-977.
39. Charlemagne D., Orlowski J., Oliviero P.et al. Alteration of Na,K-ATPase subunit mRNA and protein levels in hypertrophied rat heart. J Biol Chem. 269:1994;1541-1547.
40. Ingwall J.S., Kramer M.F., Fifer M.A.et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med. 313:1985;1050-1054.
41. Baron A.D., Steinberg H., Brechtel G., Johnson A. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol. 266:1994;E248-E253.
42. Laakso M., Edelman S.V., Brechtel G., Baron A.D. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest. 85:1990;1844-1852.
43. Thomassen A., Nielsen T.T., Bagger J.P., Henningsen P. Cardiac metabolic and hemodynamic effects of insulin in patients with coronary artery disease. Diabetes. 38:1989;1175-1180.
44. Barrett E.J., Schwartz R.G., Francis C.K., Zaret B.L. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. J Clin Invest. 74:1984;1073-1079.
45. Taegtmeyer H., Overturf M.L. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension. 11:1988;416-4126.
46. Zhang J, Duncker DJ, Xu Y, et al. Glucose uptake in the severely hypertrophied left ventricle. Circulation 1993;88:I-378.
47. Paolisso G., Gambardella A., Galzerano D.et al. Total-body and myocardial substrate oxidation in congestive heart failure. Metabolism. 43:1994;174-179.
48. Nuutila P., Koivisto V.A., Knuuti J.et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest. 89:1992;1767-1774.
49. Randle P.J., Garland P.B., Hales C.N., Newsholme E.A. The glucose fatty-acid cycle: its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet. 1:1963;785-789.
50. Maki M., Luotolahti M., Nuutila P.et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation. 93:1996;1658-1666.
51. Morgan H.E., Randle P.J., Regen D.M. Regulation of glucose uptake by muscle. 3. The effects of insulin, anoxia, salicylate and 2,4-dinitrophenol on membrane transport and intracellular phosphorylation of glucose in the isolated rat heart. Biochem J. 73:1959;573-579.
52. Neely J.R., Denton R.M., England P.J., Randle P.J. The effects of increased heart work on the tricarboxylate cycle and its interactions with glycolysis in the perfused rat heart. Biochem J. 128:1972;147-159.
53. Sugden P.H., Smith D.M. The effects of insulin on glucose uptake and lactate release in perfused working rat heart preparations. Biochem J. 206:1982;473-479.
54. Nuutila P., Knuuti M.J., Raitakari M.et al. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Am J Physiol. 267:1994;E941-E946.
55. 18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation. 91:1995;2435-2444.
56. Pollare T., Lithell H., Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension [see comments]. N Engl J Med. 321:1989;868-873.
57. Beltrami C.A., Finato N., Rocco M.et al. The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol. 27:1995;291-305.
58. Beltrami C.A., Finato N., Rocco M.et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 89:1994;151-163.
59. Saba Z., Nassar R., Ungerleider R.M., Oakeley A.E., Anderson P.A. Cardiac troponin T isoform expression correlates with pathophysiological descriptors in patients who underwent corrective surgery for congenital heart disease. Circulation. 94:1996;472-476.
60. Morano I., Hadicke K., Grom S.et al. Titin, myosin light chains and C-protein in the developing and failing human heart. J Mol Cell Cardiol. 26:1994;361-368.
61. Reinecke H., Studer R., Vetter R., Holtz J., Drexler H. Cardiac Na/Ca exchange activity in patients with end stage heart failure. Cardiovasc Res. 31:1996;48-54.
62. Studer R., Reinecke H., Bilger J.et al. Gene expression of the cardiac Na-Ca exchanger in end-stage heart failure. Circ Res. 75:1994;443-453.
63. Schwaiger M, Sun DQ, Deeb M, et al. Expression of myocardial glucose transporter (GLUT) mRNAs in patients with advanced coronary artery disease (CAD). Circulation 1994;90:I-113.
64. Sivitz W.I., Lee E.C. Assessment of glucose transporter gene expression using the polymerase chain reaction. Endocrinology. 128:1991;2387-2394.
65. DeFronzo R.A. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes. 28:1979;1095-1101.
66. Schelbert HR. Principles of positron emission tomography. In: Marcus ML, Schelbert HR, Skorton DJ, Wolf GL, editors. Cardiac imaging. Philadelphia: WB Saunders, 1991:1140-1168.
67. 18F]fluoro-D-glucose transport and phosphorylation rates in myocardium using dual-tracer kinetic experiments. FEBS Lett. 216:1987;128-132.
68. Krivokapich J., Huang S.C., Selin C.E., Phelps M.E. Fluorodeoxyglucose rate constants, lumped constant, and glucose metabolic rate in rabbit heart. Am J Physiol. 252:1987;H777-H787.
69. 18F]fluorodeoxyglucose kinetic model in calculations of myocardial glucose metabolism during ischemia. J Nucl Med. 24:1983;1060-1064.
70. Russell R.R., Mrus J.M., Mommessin J.I., Taegtmeyer H. Compartmentation of hexokinase in rat heart. A critical factor for tracer kinetic analysis of myocardial glucose metabolism. J Clin Invest. 90:1992;1972-1977.